A team of researchers from Germany is reporting that nicotinamide riboside – a form of vitamin B3 – may offer a possible treatment for Parkinson’s disease.
As with other chronic diseases, there is now clear evidence that micronutrients also play a role in Parkinson’s disease. Even before this latest research on vitamin B3, an association with the debilitating condition had already been noted for other B vitamins.
In a recent example, a study published in 2015 found that a higher intake of vitamin B6 was associated with a decreased risk of Parkinson’s. At the same time, Parkinson’s disease patients were also shown to have lower levels of vitamin B12. Research published in 2018 confirmed the link with B12, finding that lower levels of this vitamin may worsen the condition and that a daily multivitamin may slow patients’ deterioration.
With low levels of vitamin D also known to be associated with an increased risk of Parkinson’s, and pharmaceutical drugs commonly prescribed for the condition linked to an increased risk of stroke, the scientific evidence supporting safe natural health approaches to this disease continues to grow.